UC to launch center focused on ethical AI
Grant and Award Announcement
Updates every hour. Last Updated: 23-Jan-2026 10:11 ET (23-Jan-2026 15:11 GMT/UTC)
New research shows that treatment of heart failure patients with a type of anti-obesity medication reduces the environmental footprint of healthcare, as well as improving clinical outcomes.
People being treated for heart failure with GLP-1 receptor antagonists used 0.25 kg CO₂-equivalent less per person annually, compared to patients with heart failure taking a placebo. When this saving is scaled to the millions of people eligible for the treatment, the findings suggest that 2 billion kilograms of CO₂-equivalent could be saved annually.
The study is one of the first to quantify the environmental co-benefits of pharmacologic treatment. The authors hope that studies like this will empower policy makers, clinicians and patients to consider environmental outcomes alongside clinical outcomes in the future.
New research warns of declining access to safe, reliable and affordable water in the U.S., urging for better water tracking tools and immediate policy reforms.
Collaborative organizations, involving government agencies, nonprofit groups and other key stakeholders, are often created to address regional challenges such as preserving watersheds – but these organizations often fail to accomplish their stated goals. A new study suggests there is a specific administrative approach that improves the ability of these collaborative groups to deliver the services they were created to provide.